Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of Directors, which has been created in connection with the recent private investment in public equity financing which was led by Reid Hoffman. Kalir will serve as the director designee of Reprogrammed Interchange Hoffman’s investment fund.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VOR:
- Vor Bio price target lowered to $6 from $12 at JMP Securities
- Vor Biopharma Secures $55.6M for Cancer Therapy Trials
- Vor Bio prices 55.87M shares at 99.425c in private placement
- Vor Bio trem-cel relapse-rate remains low, says Oppenheimer
- Vor Bio announces updated data from Phase 1/2 VBP1-1 study
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
